A. Antoni

发表

Glucose Plasma Levels and Pregnancy Outcomes in Women with HIV

G. Guaraldi, E. Tamburrini, G. Liuzzi, 2011, HIV clinical trials.

Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study

U. Maggiore, L. Peruzzi, G. Regolisti, 2021, PloS one.

No Evidence of Autoimmune Disorders in Antiretroviral-Experienced HIV-1-Infected Individuals after Long-Term Treatment with Raltegravir

V. Vullo, L. Palmisano, D. Francisci, 2013, Antiviral therapy.

Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens.

G. Guaraldi, E. Tamburrini, A. Cavaliere, 2011, The Journal of infection.

Weight Gain during Pregnancy in Women with HIV Receiving Different Antiretroviral Regimens

G. Guaraldi, E. Tamburrini, G. Liuzzi, 2020, Antiviral therapy.

Pharmacokinetics of nelﬁnavir in HIV-1-infected pregnant and nonpregnant women

G. Guaraldi, E. Tamburrini, M. Regazzi, 2006 .

Quantitation of autoantibodies to cytokeratins in sera from patients with squamous cell carcinoma of the oesophagus.

R. Veale, A. Thornley, I. Segal, 1988, British Journal of Cancer.

Rate, Predictors, and Consequences of Late Antenatal Booking in a National Cohort Study of Pregnant Women With HIV in Italy

G. Guaraldi, I. Cetin, E. Tamburrini, 2014, HIV clinical trials.

Pregnancy Loss in Women with HIV is not Associated with HIV Markers: Data from a National Study in Italy, 2001–2018

D. Francisci, E. Tamburrini, G. Liuzzi, 2019, Mediterranean journal of hematology and infectious diseases.

HIV RNA viral Load and CD4+ T-cell Counts in HIV-Infected Pregnant Women with and without Treatment Discontinuation in Early Pregnancy

E. Ferrazzi, E. Tamburrini, A. Maccabruni, 2008, Antiviral therapy.

Hepatocellular cancer therapy in patients with HIV infection: Disparities in cancer care, trials enrolment, and cancer-related research

C. Porta, G. Missale, F. Negri, 2021, Translational oncology.

Impact of Highly Active Antiretroviral Therapy on the Natural History of Cervical Precancerous Lesions

G. Pedrazzi, T. S. Patrelli, S. Gizzo, 2014, Reproductive Sciences.

Reduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy.

A. Zoncada, A. Antoni, E. Soncini, 2007, Acta bio-medica : Atenei Parmensis.

Rate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens.

G. d’Ettorre, D. Francisci, D. Segala, 2015, AIDS research and human retroviruses.

No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis.

G. Karanikas, R. Schoen, M. Willheim, 2008, Thyroid : official journal of the American Thyroid Association.

Viro-Immunological Response of Drug-Naive HIV-1-Infected Patients Starting a First-Line Regimen with Viraemia >500,000 Copies/ml in Clinical Practice

Domenico Di Carlo, A. Antinori, M. Colafigli, 2017, Antiviral therapy.

T lymphocyte cytokine production patterns in hashimoto patients with elevated calcitonin levels and their relationship to tumor initiation.

G. Karanikas, M. Willheim, C. Pirich, 2006, Anticancer research.

Hepatitis C virus viremia following clinical resolution of acute hepatitis C.

C. Ferrari, G. Pizzocolo, T. Giuberti, 1994, Journal of hepatology.

Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors

G. d’Ettorre, V. Vullo, R. Bellagamba, 2012, International journal of STD & AIDS.